Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week

Somedeb Ball, Raktim K. Ghosh, Sariya Wongsaengsak, Dhrubajyoti Bandyopadhyay, Gopal Chandra Ghosh, Wilbert S. Aronow, Gregg C. Fonarow, Daniel J. Lenihan, Deepak L. Bhatt

Research output: Contribution to journalReview articlepeer-review

147 Scopus citations

Abstract

Immune checkpoint inhibitors (ICIs) have been an important therapeutic advance in the field of cancer medicine, resulting in a significant improvement in survival of patients with advanced malignancies. Recent reports provided greater insights into the incidence of cardiovascular adverse events (CVAEs) with ICI use. Myocarditis is the most common CVAE associated with ICI. Pericardial diseases, Takotsubo syndrome, arrhythmias, and vasculitis constitute other significant AEs. Physicians should be aware of these infrequent, but potentially fatal toxicities associated with ICIs as their therapeutic use becomes widespread with a myriad of approvals by the U.S. Food and Drug Administration. Management involves prompt administration of high-dose corticosteroids and discontinuation of ICIs in severe myocarditis. This review summarizes the most updated evidence on epidemiology, pathophysiological mechanisms, and management strategies of various CVAEs associated with ICIs. Highlights from recent guidelines published by National Comprehensive Cancer Network on ICI-related CV toxicities have also been incorporated.

Original languageEnglish
Pages (from-to)1714-1727
Number of pages14
JournalJournal of the American College of Cardiology
Volume74
Issue number13
DOIs
StatePublished - 1 Oct 2019
Externally publishedYes

Keywords

  • cancer therapeutics-related cardiac dysfunction
  • cytotoxic T lymphocyte antigen-4
  • methylprednisolone
  • myocarditis
  • programmed cell death ligand 1
  • programmed cell death protein 1
  • vasculitis

Fingerprint

Dive into the research topics of 'Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week'. Together they form a unique fingerprint.

Cite this